SOLAND DANIEL B exercised options at ACADIA PHARMACEUTICALS INC
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 6/2/2025ACC: 0001415889-25-015275
Director
Since Jun 2019
+21.90K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
4
Total transactions
31.29K acquired · 9.39K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
+9.39K
Price / share
—
Trade value
—
% of position
27.1%
5/29/2025
34.65K→44.04K
Total
Net shares
+9.39K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/29/2025 | M · Option Exercise | +9.39K | — | — | 27.1% | 34.65K | 44.04K |
| Total | +9.39K | $0.00 | ||||||
Derivative Transactions3
Restricted Stock Units
Direct
Converts to
Common Stock
9.39K shares
Shares
−9.39K
Strike price
Held after
0.00
Exercisable
—
5/29/2025
Director Stock Options (Right to Buy)
Direct
Converts to
Common Stock
13.79K shares
Shares
+13.79K
Strike price
22.29
Held after
13.79K
Exercisable
—
5/29/2025
Restricted Stock Units
Direct
Converts to
Common Stock
8.11K shares
Shares
+8.11K
Strike price
Held after
8.11K
Exercisable
—
5/29/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock9.39K shares | 5/29/2025 | M · Option Exercise | −9.39K | — | 0.00 | |
| Director Stock Options (Right to Buy) Direct | Common Stock13.79K shares | 5/29/2025 | A · Award | +13.79K | 22.29 | — | 13.79K |
| Restricted Stock Units Direct | Common Stock8.11K shares | 5/29/2025 | A · Award | +8.11K | — | 8.11K |